COVID-19 overview, timeline and key events

T. Welte (Hannover, Germany)

Source: Virtual Congress 2020 – Keynote: COVID-19 - recapitulation
Session: Keynote: COVID-19 - recapitulation
Session type: COVID-19
Number: 3603

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Welte (Hannover, Germany). COVID-19 overview, timeline and key events. Virtual Congress 2020 – Keynote: COVID-19 - recapitulation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Keynote: COVID-19 overview, timeline, and key events
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

How to stop LC-fILD progression: an overview of modern therapeutic strategies
Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists
Year: 2021


Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Year: 2021


Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021


Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021


Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis
Year: 2021


General overview of system biology and network analysis
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016


Guidance production before evidence generation for critical issues: the example of COVID-19
Source: Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020
Year: 2020



Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review
Source: Eur Respir J, 49 (6) 1700204; 10.1183/13993003.00204-2017
Year: 2017



Historical overview: On the evolution of respiratory support for neonates
Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)
Year: 2009

The time is right for an international PCD disease registry: insight and ongoing research activities
Source: Eur Respir J, 49 (6) 1700357; 10.1183/13993003.00357-2017
Year: 2017



TH2-high asthma: a practical approach with cases and interactive questions
Source: International Congress 2019 – Severe asthma guidelines: update 2019
Year: 2019


Reference article: NIV in the acute setting: technical aspects, initiation, monitoring and choice of interface
Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course
Year: 2012

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
Source: Eur Respir J, 56 (3) 2002114; 10.1183/13993003.02114-2020
Year: 2020



Defining a review question and writing a protocol
Source: International Congress 2015 – How to perform and interpret systematic reviews and meta-analyses
Year: 2015